Dendreon Employee Directory
Biotechnology ResearchCalifornia, United States501-1000 Employees
Dendreon is a biotechnology company focused on immunotherapy, developing treatments that harness a patient's own immune cells. Its flagship therapy, PROVENGE (sipuleucel-T), is FDA-approved for men with advanced prostate cancer. Since 2010, more than 40,000 U.S. patients have been prescribed PROVENGE, and the company is exploring its use in earlier disease stages. Based in Seal Beach, California, Dendreon is a commercial-stage biopharmaceutical firm within the biotechnology research industry. The information indicates its activities revolve around immunotherapy for prostate cancer, with ongoing evaluation of PROVENGE in earlier-stage disease.